{2 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 12.5 - < 25 kg]

RxCUI
2706552
RxNorm name
{2 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 12.5 - < 25 kg]
Display name
{2 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 12.5 - < 25 kg]
Full name
{2 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 12.5 - < 25 kg]
Term type
BPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125706ryoncilremestemcel-L-rknd351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RYONCILREMESTEMCEL-L-RKNDMesoblasta4e0918f-7444-4694-adeb-d38d983456592025-09-11Warnings, Adverse reactionsExact identifier
rxcui: 2706552

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a4e0918f-7444-4694-adeb-d38d98345659{2 (3.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]) } Pack [Ryoncil Kit 12.5 - < 25 kg] [BPCK] · Ryoncil Kit Patient Weight 12.5 - < 25 KG [PSN] · Ryoncil Kit Patient Weight 12.5 - < 25 KG [SY]35These highlights do not include all the information needed to use RYONCIL ® safely and effectively. See full prescribing information for RYONCIL ® . RYONCIL ® (remestemcel-L-rknd) suspension for intravenous infusion Initial U.S. Approval: December 202420250911